SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Homozygous missense WIPI2 variants cause a congenital disorder of autophagy with neurodevelopmental impairments of variable clinical severity and disease course.

Maroofian, R; Gubas, A; Kaiyrzhanov, R; Scala, M; Hundallah, K; Severino, M; Abdel-Hamid, MS; Rosenfeld, JA; Ebrahimi-Fakhari, D; Ali, Z; et al. Maroofian, R; Gubas, A; Kaiyrzhanov, R; Scala, M; Hundallah, K; Severino, M; Abdel-Hamid, MS; Rosenfeld, JA; Ebrahimi-Fakhari, D; Ali, Z; Rahim, F; Houlden, H; Tooze, SA; Alsaleh, NS; Zaki, MS (2021) Homozygous missense WIPI2 variants cause a congenital disorder of autophagy with neurodevelopmental impairments of variable clinical severity and disease course. Brain Commun, 3 (3). fcab183. ISSN 2632-1297 https://doi.org/10.1093/braincomms/fcab183
SGUL Authors: Maroofian, Reza

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

WIPI2 is a member of the human WIPI protein family (seven-bladed b-propeller proteins binding phosphatidylinositols, PROPPINs), which play a pivotal role in autophagy and has been implicated in the pathogenesis of several neurological conditions. The homozygous WIPI2 variant c.745G>A; p.(Val249Met) (NM_015610.4) has recently been associated with a neurodevelopmental disorder in a single family. Using exome sequencing and Sanger segregation analysis, here, two novel homozygous WIPI2 variants [c.551T>G; p.(Val184Gly) and c.724C>T; p.(Arg242Trp) (NM_015610.4)] were identified in four individuals of two consanguineous families. Additionally, follow-up clinical data were sought from the previously reported family. Three non-ambulant affected siblings of the first family harbouring the p.(Val184Gly) missense variant presented with microcephaly, profound global developmental delay/intellectual disability, refractory infantile/childhood-onset epilepsy, progressive tetraplegia with joint contractures and dyskinesia. In contrast, the proband of the second family carrying the p.(Arg242Trp) missense variant, similar to the initially reported WIPI2 cases, presented with a milder phenotype, encompassing moderate intellectual disability, speech and visual impairment, autistic features, and an ataxic gait. Brain MR imaging in five patients showed prominent white matter involvement with a global reduction in volume, posterior corpus callosum hypoplasia, abnormal dentate nuclei and hypoplasia of the inferior cerebellar vermis. To investigate the functional impact of these novel WIPI2 variants, we overexpressed both in WIPI2-knockout HEK293A cells. In comparison to wildtype, expression of the Val166Gly WIPI2b mutant resulted in a deficient rescue of LC3 lipidation whereas Arg224Trp mutant increased LC3 lipidation, in line with the previously reported Val231Met variant. These findings support a dysregulation of the early steps of the autophagy pathway. Collectively, our findings provide evidence that biallelic WIPI2 variants cause a neurodevelopmental disorder of variable severity and disease course. Our report expands the clinical spectrum and establishes WIPI2-related disorder as a congenital disorders of autophagy.

Item Type: Article
Additional Information: © The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: WIPI2, WIPI2b, autophagy, congenital disorders of autophagy, neurodevelopmental disorder, WIPI2, WIPI2b, autophagy, neurodevelopmental disorder, congenital disorders of autophagy, WIPI2, WIPI2b, autophagy, neurodevelopmental disorder, congenital disorders of autophagy
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Brain Commun
ISSN: 2632-1297
Language: eng
Dates:
DateEvent
3 September 2021Published
30 June 2021Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
G0601943Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MR/S005021/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MR/S01165X/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
P50 HD105351NICHD NIH HHSUNSPECIFIED
WT093205MAWellcome Trusthttp://dx.doi.org/10.13039/100004440
WT104033AIAWellcome Trusthttp://dx.doi.org/10.13039/100004440
165908Wellcome Trusthttp://dx.doi.org/10.13039/100004440
R01NS107428National Institute of Neurological Disorders and Strokehttp://dx.doi.org/10.13039/100000065
FC001187Cancer Research UKhttp://dx.doi.org/10.13039/501100000289
FC001187Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
FC001187Wellcome Trusthttp://dx.doi.org/10.13039/100004440
PubMed ID: 34557665
Web of Science ID: WOS:000734327400054
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114403
Publisher's version: https://doi.org/10.1093/braincomms/fcab183

Actions (login required)

Edit Item Edit Item